Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration

Ye,Hongnan; Zhang,Youyi; Geng,Li; Li,Zijian

doi:10.3892/ijo.2014.2748

Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration

Authors:
- Hongnan Ye
- Youyi Zhang
- Li Geng
- Zijian Li
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, Peking University Third Hospital, Beijing 100191, P.R. China, Institute of Vascular Medicine, Peking University Third Hospital and Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptide, Ministry of Health, Beijing 100191, P.R. China
Published online on: November 13, 2014 https://doi.org/10.3892/ijo.2014.2748
Pages: 757-763

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine Cdc42 expression in cervical cancer and explore its effects on invasion and migration capability of cervical cancer cells. Immunohistochemistry was used to detect Cdc42 expression in normal cervical tissues as well as CIN I or below, CIN II or above, and cervical cancer tissues. Western blot analysis was used to explore Cdc42 expression in normal cervical cell line Crl-2614 and cervical cancer cell line HeLa. Plasmids of constitutively active Cdc42 (Cdc42 CA), wild-type Cdc42 (Cdc42 WT) and dominant negative Cdc42 (Cdc42 DN) were transfected, respectively, into HeLa cells to investigate the impacts of Cdc42 on migration and invasion of cervical cancer cells using Transwell and on cytoskeleton microfilaments using confocal microscopy after immunofluorescence staining. Cdc42 expression was gradually increased in the order of cervical tissues with CIN I or below, CIN II or above and cancer, showing significant difference (P<0.05), and was significantly higher in HeLa cells than in Crl-2614 cells (P<0.05). Migration ability of HeLa cells transfected with Cdc42 CA was significantly higher than that of non-transfected, as well as Cdc42 WT- or Cdc42 DN-transfected HeLa cells (P<0.05). Overexpression of Cdc42 CA can promote filopodia formation in HeLa cells. We concluded that Cdc42 overexpression significantly improved the ability of cervical cancer cells to migrate possibly due to improved pseudopodia formation.

View Figures

View References

1	Bast RC Jr, Hennessy B and Mills GB: The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 9:415–428. 2009. View Article : Google Scholar : PubMed/NCBI
2	Cardone RA, Casavola V and Reshkin SJ: The role of disturbed pH dynamics and the Na⁺/H⁺ exchanger in metastasis. Nat Rev Cancer. 5:786–795. 2005. View Article : Google Scholar : PubMed/NCBI
3	Sinha S and Yang W: Cellular signaling for activation of Rho GTPase Cdc42. Cell Signal. 20:1927–1934. 2008. View Article : Google Scholar : PubMed/NCBI
4	Tsang CM, Lau EP, Di K, et al: Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med. 24:131–138. 2009.PubMed/NCBI
5	Zhang S, Schafer-Hales K, Khuri FR, Zhou W, Vertino PM and Marcus AI: The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Res. 68:740–748. 2008. View Article : Google Scholar : PubMed/NCBI
6	Munoz N, Castellsague X, de Gonzalez AB, et al: Chapter 1: HPV in the etiology of human cancer. Vaccine. 24(Suppl 3): S1–S10. 2006. View Article : Google Scholar
7	Woodman CB, Collins SI and Young LS: The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 7:11–22. 2007. View Article : Google Scholar
8	Lagunas-Martinez A, Madrid-Marina V and Gariglio P: Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. Biochim Biophys Acta. 1805:6–16. 2010.
9	Zhou Q, Huang MZ, Huang S, et al: Meta-analysis of factors affecting the incidence of cervical cancer in Chinese married women. Chin J Cancer. 21:125–129. 2011.
10	Kantrardzic N: Current chemoradiation for cervical cancer: results of five randomized trials. Med Arh. 64:368–370. 2010.
11	Jin ZH, Liao GW and Jiang N: Clinical analysis of 91 cases of young patients with recurent and metastized cervical cancer. Practical J Cancer. 21:502–503. 2006.
12	Villalonga P and Ridley AJ: Rho GTPases and cell cycle control. Growth Factors. 24:159–164. 2006. View Article : Google Scholar : PubMed/NCBI
13	Heasman SJ and Ridley AJ: Mammalian Rho GTPases: new insights into their, functions from in vivo studies. Nat Rev Mol Cell Biol. 9:690–701. 2008. View Article : Google Scholar : PubMed/NCBI
14	Bustelo XR, Sauzeau V and Berenjeno IM: GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays. 29:356–370. 2007. View Article : Google Scholar : PubMed/NCBI
15	Ellenbroek SI and Collard JG: Rho GTPases: functions and association with cancer. Clin Exp Metastasis. 24:657–672. 2007. View Article : Google Scholar : PubMed/NCBI
16	Vega FM and Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett. 582:2093–2101. 2008. View Article : Google Scholar : PubMed/NCBI
17	Fritz G, Just I and Kaina B: Rho GTPases are overexpressed in human tumors. Int J Cancer. 81:682–687. 1999. View Article : Google Scholar : PubMed/NCBI
18	Yilmaz M and Christofori G: Mechanisms of motility in metastasizing cells. Mol Cancer Res. 8:629–642. 2010. View Article : Google Scholar : PubMed/NCBI
19	Bouzahzah B, Albanese C, Ahmed F, et al: Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med. 7:816–830. 2001.
20	Johnson E, Seachrist DD, DeLeon-Rodriguez CM, et al: HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. Biol Chem. 285:29491–29501. 2010. View Article : Google Scholar
21	Faix J, Breitsprecher D, Stradal TE, et al: Complex models for simple rods. Int J Biochem Cell Biol. 41:1656–1664. 2009. View Article : Google Scholar : PubMed/NCBI
22	Buccione R, Caldieri G and Ayala I: Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 28:137–149. 2009. View Article : Google Scholar : PubMed/NCBI
23	Fisher KE, Sacharidou A, Stratman AN, et al: MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices. J Cell Sci. 122:4558–4569. 2009. View Article : Google Scholar : PubMed/NCBI
24	Yamaguchi H, Lorenz M, Kempiak S, et al: Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 168:441–452. 2005. View Article : Google Scholar : PubMed/NCBI
25	Pichot CS, Arvanitis C, Hartig SM, et al: Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASP. Cancer Res. 70:8347–8356. 2010. View Article : Google Scholar : PubMed/NCBI
26	Stylli SS, Kaye AH and Lock P: Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci. 15:725–737. 2008. View Article : Google Scholar : PubMed/NCBI
27	Sahai E: Mechanisms of cancer cell invasion. Curr Opin Genet Dev. 15:87–96. 2005. View Article : Google Scholar : PubMed/NCBI